Cargando…

Strategies of drug companies to optimize the sales of their psychiatric drugs

Detalles Bibliográficos
Autor principal: Whitaker, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332913/
http://dx.doi.org/10.1186/1471-244X-7-S1-S90
_version_ 1782230331144798208
author Whitaker, Robert
author_facet Whitaker, Robert
author_sort Whitaker, Robert
collection PubMed
description
format Online
Article
Text
id pubmed-3332913
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33329132012-04-24 Strategies of drug companies to optimize the sales of their psychiatric drugs Whitaker, Robert BMC Psychiatry Oral Presentation BioMed Central 2007-12-19 /pmc/articles/PMC3332913/ http://dx.doi.org/10.1186/1471-244X-7-S1-S90 Text en Copyright ©2007 Whitaker; licensee BioMed Central Ltd.
spellingShingle Oral Presentation
Whitaker, Robert
Strategies of drug companies to optimize the sales of their psychiatric drugs
title Strategies of drug companies to optimize the sales of their psychiatric drugs
title_full Strategies of drug companies to optimize the sales of their psychiatric drugs
title_fullStr Strategies of drug companies to optimize the sales of their psychiatric drugs
title_full_unstemmed Strategies of drug companies to optimize the sales of their psychiatric drugs
title_short Strategies of drug companies to optimize the sales of their psychiatric drugs
title_sort strategies of drug companies to optimize the sales of their psychiatric drugs
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332913/
http://dx.doi.org/10.1186/1471-244X-7-S1-S90
work_keys_str_mv AT whitakerrobert strategiesofdrugcompaniestooptimizethesalesoftheirpsychiatricdrugs